ConductScience.org, home

Paper5206

Pharmacological evidence for a central alpha-sympathomimetic mechanism controlling blood pressure and heart rate.

Laubie M and 7 others. Circ Res, 1976. Cited by 38 papers, by iCite.

Cite this record

ConductScience Library. Pharmacological evidence for a central alpha-sympathomimetic mechanism controlling blood pressure and heart rate. Papers, record 5206. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5206

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacological evidence for a central alpha-sympathomimetic mechanism controlling blood pressure and heart rate.
PubMed
Journal
Circ Res
PubMed
Year
1976
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
1.86
iCite
Revised in PubMed
2019-07-06
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Laubie MM
2Delbarre BB
3Bogaievsky DD
4Bogaievsky YY
5Tsoucaris-Kupfer DD
6Senon DD
7Schmitt HH
8Schmitt HH

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood PressureMajor topic
BrainMajor topic
Heart RateMajor topic
Receptors, AdrenergicMajor topic
Vasomotor SystemMajor topic
Acetylcholine
Adrenergic alpha-Antagonists
Animals
Cerebral Cortex
Clonidine
Cyclic AMP
Fentanyl
Injections, Intraventricular
Medulla Oblongata
Neurotransmitter Agents
Oxotremorine
Parasympathomimetics
Physostigmine
Pressoreceptors

Source PubMed

Download CSV of topics

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
9050981The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.J Hypertens Suppl1997https://conductscience.org/library/papers/9050981PubMed
8821553A comparative study of the reversal by different alpha 2-adrenoceptor antagonists of the central sympatho-inhibitory effect of clonidine.Br J Pharmacol1996https://conductscience.org/library/papers/8821553PubMed
6994788Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity.Br J Clin Pharmacol1980https://conductscience.org/library/papers/6994788PubMed
6150737Evidence for a peripheral component in the sympatholytic effect of clonidine in rats.Br J Pharmacol1984https://conductscience.org/library/papers/6150737PubMed
6125192Relationship of plasma catecholamines to blood pressure in hypertensive patients during beta-adrenoceptor blockade with and without intrinsic sympathomimetic activity.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6125192PubMed
6104975Pharmacology of centrally acting hypotensive drugs.Br J Clin Pharmacol1980https://conductscience.org/library/papers/6104975PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5206

GET https://conductscience.org/api/papers/v1/5206/authors